BAX Baxter International Inc

Price (delayed)

$80.2

Market cap

$40.09B

P/E Ratio

36.13

Dividend/share

$1.05

EPS

$2.22

Enterprise value

$43.59B

Every day, millions of patients and caregivers rely on Baxter's leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, it has been operating ...

Highlights
The EPS has grown by 23% YoY and by 5% from the previous quarter
BAX's net income is up by 21% year-on-year and by 4.9% since the previous quarter
BAX's P/E is 8% below its last 4 quarters average of 39.5 but 4.6% above its 5-year quarterly average of 34.7
The quick ratio is down by 26% year-on-year and by 3.8% since the previous quarter
The gross margin is down by 6% year-on-year

Key stats

What are the main financial stats of BAX
Market
Shares outstanding
499.91M
Market cap
$40.09B
Enterprise value
$43.59B
Valuations
Price to earnings (P/E)
36.13
Price to book (P/B)
4.75
Price to sales (P/S)
3.31
EV/EBIT
29.02
EV/EBITDA
18.45
EV/Sales
3.57
Earnings
Revenue
$12.2B
EBIT
$1.5B
EBITDA
$2.36B
Free cash flow
$1.35B
Per share
EPS
$2.22
Free cash flow per share
$2.69
Book value per share
$16.89
Revenue per share
$24.25
TBVPS
$29.07
Balance sheet
Total assets
$19.68B
Total liabilities
$11.15B
Debt
$6.64B
Equity
$8.49B
Working capital
$4.66B
Liquidity
Debt to equity
0.78
Current ratio
2.39
Quick ratio
1.54
Net debt/EBITDA
1.48
Margins
EBITDA margin
19.4%
Gross margin
39.1%
Net margin
9.2%
Operating margin
13.9%
Efficiency
Return on assets
5.7%
Return on equity
13.1%
Return on invested capital
10.2%
Return on capital employed
9.2%
Return on sales
12.3%
Dividend
Dividend yield
1.31%
DPS
$1.05
Payout ratio
47.3%

BAX stock price

How has the Baxter International stock price performed over time
Intraday
-0.46%
1 week
-2.14%
1 month
8.42%
1 year
0.83%
YTD
-0.05%
QTD
-0.37%

Financial performance

How have Baxter International's revenue and profit performed over time
Revenue
$12.2B
Gross profit
$4.76B
Operating income
$1.69B
Net income
$1.12B
Gross margin
39.1%
Net margin
9.2%
BAX's net income is up by 21% year-on-year and by 4.9% since the previous quarter
Baxter International's net margin has increased by 14% YoY and by 2.2% from the previous quarter
The operating margin has decreased by 11% YoY but it has increased by 3% from the previous quarter
The revenue is up by 7% year-on-year and by 3.2% since the previous quarter

Growth

What is Baxter International's growth rate over time

Valuation

What is Baxter International stock price valuation
P/E
36.13
P/B
4.75
P/S
3.31
EV/EBIT
29.02
EV/EBITDA
18.45
EV/Sales
3.57
The EPS has grown by 23% YoY and by 5% from the previous quarter
BAX's P/E is 8% below its last 4 quarters average of 39.5 but 4.6% above its 5-year quarterly average of 34.7
BAX's P/B is 6% above its 5-year quarterly average of 4.5
The company's equity rose by 4.5% YoY
The revenue is up by 7% year-on-year and by 3.2% since the previous quarter
BAX's P/S is 5% below its last 4 quarters average of 3.5 and 2.4% below its 5-year quarterly average of 3.4

Efficiency

How efficient is Baxter International business performance
The ROS has grown by 40% YoY and by 3.4% from the previous quarter
The ROIC has increased by 40% YoY and by 6% from the previous quarter
The ROA has grown by 14% YoY and by 6% from the previous quarter
The company's return on equity rose by 11% YoY and by 4% QoQ

Dividends

What is BAX's dividend history
DPS
$1.05
Dividend yield
1.31%
Payout ratio
47.3%
Recent dividends

Financial health

How did Baxter International financials performed over time
The total assets is 77% more than the total liabilities
The quick ratio is down by 26% year-on-year and by 3.8% since the previous quarter
The current ratio fell by 20% YoY and by 3.2% QoQ
Baxter International's debt is 22% less than its equity
The debt to equity has declined by 7% year-on-year
The company's equity rose by 4.5% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.